{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:19:32Z","timestamp":1778998772874,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.ophtha.2006.08.044","type":"journal-article","created":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T07:20:12Z","timestamp":1169018412000},"page":"724-731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Evaluation of Intravitreal Kenalog Toxicity in Humans"],"prefix":"10.1016","volume":"114","author":[{"given":"Yaron","family":"Lang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Leibu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nir","family":"Shoham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ido","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2006.08.044_bib1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema","volume":"109","author":"Martidis","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.08.044_bib2","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ophtha.2004.05.025","article-title":"Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment","volume":"111","author":"Sutter","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.08.044_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/bjo.2004.046391","article-title":"Diffuse diabetic macular edema treated by intravitreal triamcinolone acetonide: a comparative, non-randomized study","volume":"89","author":"Jonas","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib4","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00006982-200510000-00002","article-title":"Intravitreal triamcinolone acetonide for diabetic macular edema","volume":"25","author":"Chieh","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2006.08.044_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bjo.86.2.247","article-title":"Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion","volume":"86","author":"Greenberg","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/112067210501500615","article-title":"Intravitreal triamcinolone acetonide for the treatment of central retinal vein occlusion","volume":"15","author":"Jonas","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib7","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archopht.122.8.1131","article-title":"Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion","volume":"122","author":"Ip","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib8","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/00006982-200510000-00005","article-title":"Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion","volume":"25","author":"Cekic","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2006.08.044_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.88.1.154","article-title":"Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion","volume":"88","author":"Chen","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00006982-200510000-00006","article-title":"Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion","volume":"25","author":"Cekic","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2006.08.044_bib11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","article-title":"Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study","volume":"108","author":"Antcliff","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.08.044_bib12","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2005.06.009","article-title":"Outcome of intravitreal triamcinolone in uveitis","volume":"112","author":"Kok","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.08.044_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1442-9071.1998.tb01330.x","article-title":"Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up","volume":"26","author":"Challa","year":"1998","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.eye.6701438","article-title":"Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide: a prospective comparative nonrandomized study","volume":"19","author":"Jonas","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2006.08.044_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ophtha.2004.08.012","article-title":"Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization","volume":"112","author":"Spaide","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.08.044_bib16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bjo.2003.027177","article-title":"Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration","volume":"88","author":"Rechtman","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006982-200005000-00024","article-title":"Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy","volume":"20","author":"Peyman","year":"2000","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2006.08.044_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00006982-200312000-00004","article-title":"Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy","volume":"23","author":"Furino","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2006.08.044_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ophtha.2003.05.034","article-title":"Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide","volume":"111","author":"Sonoda","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.08.044_bib20","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/00006982-200512000-00003","article-title":"Triamcinolone-assisted internal limiting membrane peeling","volume":"25","author":"Shah","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2006.08.044_bib21","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ajo.2004.06.067","article-title":"Intravitreal triamcinolone acetonide and intraocular pressure","volume":"138","author":"Smithen","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/archopht.122.3.336","article-title":"Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial","volume":"122","author":"Gillies","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ajo.2004.06.041","article-title":"Safety of intravitreal high-dose reinjections of triamcinolone acetonide","volume":"138","author":"Jonas","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0008-4182(05)80119-X","article-title":"Complications of intravitreal injection of triamcinolone acetonide","volume":"40","author":"Ozkiris","year":"2005","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ophtha.2004.10.042","article-title":"Intraocular pressure elevation after intravitreal triamcinolone acetonide injection","volume":"112","author":"Jonas","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.08.044_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2004.07.017","article-title":"Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract","volume":"112","author":"Gillies","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.08.044_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bjo.87.1.24","article-title":"Intraocular pressure after intravitreal injection of triamcinolone acetonide","volume":"87","author":"Jonas","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1177\/112067210501500407","article-title":"Frequency of cataract surgery after intravitreal injection of high-dosage triamcinolone acetonide","volume":"15","author":"Jonas","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib29","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ajo.2005.01.022","article-title":"Cataract progression after intravitreal triamcinolone injection","volume":"139","author":"Cekic","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9394(03)00483-5","article-title":"Acute endophthalmitis following intravitreal triamcinolone acetonide injection","volume":"136","author":"Moshfeghi","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ajo.2004.03.025","article-title":"Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema","volume":"138","author":"Moshfeghi","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib32","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/bjo.2004.041707","article-title":"Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study","volume":"88","author":"Ciardella","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib33","first-page":"3053","article-title":"The effects of Depo-Medrol preservative on the rabbit visual system","volume":"32","author":"Loewenstein","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2006.08.044_bib34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0002-9394(81)90013-1","article-title":"The lack of toxicity of intravitreal administered triamcinolone acetonide","volume":"91","author":"McCuen","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib35","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/archopht.123.11.1563","article-title":"Electroretinographic effects of an intravitreal injection of triamcinolone in rabbit retina","volume":"123","author":"Dierks","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib36","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3928\/1542-8877-20001101-07","article-title":"Retinal toxicity of triamcinolone acetonide in silicone-filled eyes","volume":"31","author":"Kivilcim","year":"2000","journal-title":"Ophthalmic Surg Lasers"},{"key":"10.1016\/j.ophtha.2006.08.044_bib37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0002-9394(86)90593-3","article-title":"Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations","volume":"101","author":"Hida","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00006982-200603000-00014","article-title":"Intravitreal toxicity of the Kenalog vehicle (benzyl alcohol) in rabbits","volume":"26","author":"Morrison","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2006.08.044_bib39","doi-asserted-by":"crossref","unstructured":"Marmor MF, Zrenner E, International Society for Clinical Electrophysiology of Vision. Standard for clinical electrophysiology (1999 update). Doc Ophthalmol 1998\u20131999;97:143\u201356.","DOI":"10.1023\/A:1002016531591"},{"key":"10.1016\/j.ophtha.2006.08.044_bib40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00207350","article-title":"New approaches to ophthalmic electrodiagnosis by retinal oscillatory potential, drug-induced responses from retinal pigment epithelium and cone potential","volume":"48","author":"Yonemura","year":"1979","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib41","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0161-6420(96)30383-7","article-title":"Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide","volume":"103","author":"Danis","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.08.044_bib42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archopht.119.3.399","article-title":"Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model","volume":"119","author":"Ciulla","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-9394(82)90130-1","article-title":"The clearance of intravitreal triamcinolone acetonide","volume":"93","author":"Schindler","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.08.044_bib44","first-page":"2773","article-title":"A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy","volume":"33","author":"Holopigian","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2006.08.044_bib45","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1755-3768.1980.tb08312.x","article-title":"The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy","volume":"58","author":"Simonsen","year":"1980","journal-title":"Acta Ophthalmol (Copenh)"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642006012784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642006012784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:50:34Z","timestamp":1758981034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642006012784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0161642006012784"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2006.08.044","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Intravitreal Kenalog Toxicity in Humans","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2006.08.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}